Trevi Therapeutics, Inc. (TRVI)
13.30
+0.22
(+1.68%)
USD |
NASDAQ |
Mar 06, 16:00
13.29
-0.01
(-0.08%)
After-Hours: 20:00
Trevi Therapeutics EPS Diluted (Quarterly) : -0.0813 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 0.1493 |
| Bristol Myers Squibb Co. | 0.5326 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.80M |
| Total Expenses (Quarterly) | 11.80M |
| Enterprise Value | 1.511B |
| Earnings Yield | -2.79% |
| Normalized Earnings Yield | -2.792 |